Navigation Links
Tengion Provides Business Update and Reports Third Quarter 2011 Financial Results
Date:11/14/2011

al models have been conducted for a sufficiently long period of time to demonstrate durability and an impact on survival.

Building on these results, Tengion is completing the analysis of these studies, and focusing its efforts on completing preclinical work on product formulation and delivery.  The Company expects to submit a pre-IND filing to the FDA during the first half of 2012 and is actively seeking collaboration partners for this program.

Financial Update  

For the nine months ended September 30, 2011, the Company reported an adjusted net loss of $18.2 million, or $0.87 per basic and diluted common share, compared with an adjusted net loss of $19.7 million, or $2.42 per basic and diluted common share, for the same period in 2010.  The decreased adjusted net loss for the 2011 period was primarily due to a decrease in interest expense of $1.0 million due to lower average debt facility balances outstanding in 2011 and a decrease in depreciation expense of $0.5 million due a change in the estimated useful life of our leasehold improvements associated with our laboratory space in Winston-Salem, North Carolina.  In May 2011, the Company exercised a five-year renewal option under its lease for the laboratory space.  The amended lease extends the lease term to October 2016.  The adjusted net loss per basic and diluted common share for the nine months ended September 30, 2011 was significantly affected by the issuance of common stock in connection with equity financings completed in April 2010 and March 2011.

For the third quarter ended September 30, 2011, the Company reported an adjusted net loss of $5.1 million, or $0.21 per basic and diluted common share, compared with an adjusted net loss of $6.7 million, or $0.54 per basic and diluted common share, for the same period in 2010.  The decreased adjusted net loss for the 2011 period was primarily due to a decrease in research and development expen
'/>"/>

SOURCE Tengion, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Tengion Appoints Scott Flora to Board of Directors
2. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
3. Tengion Provides Update on Neo-Urinary Conduit Clinical Trial
4. Tengion Announces FDA Orphan-Drug Designation for Neo-Urinary Conduit
5. Tengion Presents New Data in Nine Posters and Two Oral Presentations at TERMIS North America Annual Meeting
6. Tengion Advances Clinical Trial for Neo-Urinary Conduit™ in Bladder Cancer Patients
7. Tengion Provides Business Update and Reports Third Quarter 2010 Financial Results
8. Tengion Reviews Pipeline Progress at First Analyst and Investor Meeting; Strategic & Clinical Updates Provided for Regenerative Medicine Programs
9. Tengion Announces First Implantation of Neo-Urinary Conduit™ in Initial Clinical Trial in Patients with Bladder Cancer
10. Tengion Presents New Data Demonstrating Functional Regeneration in a Diabetic Chronic Kidney Failure Model at the International Society for Cellular Therapy
11. Tengion Appoints Sunita B. Sheth, M.D., Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... LUNGevity Foundation, the nation,s leading lung ... (FDA) approval of Bristol Myers Squibb,s new immunotherapy ... add another critical new treatment option to fight ... patient,s own immune system to fight cancerous cells. ... patients with squamous cell lung cancer, a population ...
(Date:3/5/2015)... --Research and Markets ( http://www.researchandmarkets.com/research/gl7m98/japan_pharma ) has ... 2015: Year to Watch out for Authorized Generics (AGs), ... offering. The new pricing system adopted ... (Annexure 1) is a game changer initiative. It pains ... The most of the companies are revalidating their domestic ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... of the "Global Rising Stars Outlook 2015" ... for treating diseases are being sought after with fresh ... discovered. One field which is poised to bring a ... the next decades is the Stem cell therapy/Regenerative Medicine ...
Breaking Medicine Technology:LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 2LUNGevity Foundation Applauds FDA Approval of Immunotherapy Drug Opdivo 3Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Global Pharma Rising Stars Outlook 2015 2
... SAN FRANCISCO , April 21, 2010 ... announced an agreement,with 100X Imaging, Inc. (100X Imaging) to develop and ... exclusive,rights to develop and market products based on this image indexing ... ...
... March 23 The innovative therapies for lung failure from medical device company Novalung GmbH continue to gain acceptance.  Additional financing will allow the Talheim ( Germany ) based ... ... ... ...
Cached Medicine Technology:Strand to Develop and Market Breakthrough Software Solutions to Manage Insights Associated With Microscopy Images 2Novalung Records 50% Growth 2Novalung Records 50% Growth 3
(Date:3/5/2015)... Leading nutritional supplement provider Metabolic Nutrition ... and Arnold Fitness EXPO in Columbus, Ohio ... a display booth featuring free samples of its superior ... class-leading fat burner Synedrex. The company will also be ... its top-of-the-line supplements and miniature action figures of its ...
(Date:3/5/2015)... 2015 Think it’s tough to get kids ... get them to brush their teeth. That’s a finding from ... by Delta Dental(1) in conjunction with National Parenting Month in ... getting kids to brush their teeth is one of the ... slightly higher than getting children to eat vegetables regularly (42 ...
(Date:3/5/2015)... 05, 2015 The recent influx of ... promises is alarming, with more and more internet ads ... actual prescription, making it easy for more people to ... their money and endanger their health. The company urges ... prescription online diet pills: , 1.    Where are the products ...
(Date:3/5/2015)... The MTC 5-day Fundamental Implantology Course has been ... variety of dental disciplines, to offer implant placement treatment ... onset we wanted this course to be a truly ... excellence of the lecturers and the sheer energy and ... satisfied our aims." , Unlike large-scale training operations, ...
(Date:3/5/2015)... 05, 2015 Hope For The Warriors® is ... Shoot to be held at Beretta Shooting Grounds (Dover Furnace) ... proceeds from the event will benefit Hope For The Warriors®, ... restoring the family unit, and restoring hope for our service ... our nation’s heroes through a day of clay shooting at ...
Breaking Medicine News(10 mins):Health News:Metabolic Nutrition Exhibiting at 2015 Arnold Sports Festival and Fitness EXPO This Week 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 2Health News:Delta Dental Survey Says Parents Have Harder Time Getting Kids to Brush than to Eat Vegetables 3Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 2Health News:Diet Doc Announces Four Simple Questions that Dieters Must Ask Prior to Purchasing Online Diet Pills 3Health News:MIS Global Training Center (MTC) Launches its Fundamental Implantology Course for Doctors - with a Difference 2Health News:Hope For The Warriors Announces New York Clay Shoot to Benefit Military Families 2
... Researchers have been able to identify neural signatures ... record, measure and analyze both behavior and ... ,Researchers used a specially designed dual-electroencephalogram (EEG) and ... in this study, The Phi Complex as a ...
... to become one of the first major universities in the ... campus. University officials intend to give the Fayetteville campus ... to the policy: the ban is scheduled to go into ... health issue, said Mary Alice Serafini, assistant vice chancellor for ...
... the Ontario Cancer Institute at Princess Margaret Hospital have successfully ... new cancer drug that is triggered by a laser ... ,In a study published today in the Proceedings of ... Scientist - Division of Biophysics and Bioimaging, Joey and Toby ...
... (Childrens Hospital Boston) and colleagues have identified the cancer ... of childhood. ,'Identifying the cancer stem ... in ERMS will likely lead to new insights into ... explains Dr. Zon. ,Rhabdomyosarcoma (RMS) is an ...
... Rsearchers at the University of Florida, found that self-confidence ... more over a lifetime. Believing in yourself ... the study found. ,People with high opinions ... salaries in middle age than their less confident counterparts, ...
... Desperate Housewives actress -Terri Hatcher, has a unique way of using ... ,The actress is following the advice of her Pharmacist ... and sour wine in a bathwater. It is well is a ... good after four to five days. ,"When you're alone ...
Cached Medicine News:Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 2Health News:New Brain Neuromarker May Shed Light on Autism and Schizophrenia 3Health News:University of Arkansas to Ban Tobacco from Its Campus 2Health News:University of Arkansas to Ban Tobacco from Its Campus 3Health News:Scientists Activate New Cancer Drug Using Light and Oxygen 2Health News:Pediatric Cancer Stem Cell Identified 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 2Health News:Teenage Self Confidence Can Translate Later into Material Wealth 3
... (Nidek Advanced Vision Information System) is an ... software on a platform designed to communicate ... The network can be expanded in various ... to Nidek products but also to fundus ...
... OcuLight family of infrared laser photocoagulators includes ... These diode lasers serve as a single ... applications, require no regular maintenance or special ... compact design. The OcuLight SLx is now ...
The simplest, most accurate Ortho-K lens fitting system ever!...
... gas permeable contact lenses used for corneal ... nearsightedness (myopia). The patient wears the lenses ... wakening. During the day, nearsightedness is corrected ... Quadra RG contact lenses apply slight pressure ...
Medicine Products: